DE602004018675D1 - DARSTELLUNG VON 1-AZA-2-OXADIBENZOÄe,hÜAZULENEN UND DEREN VERWENDUNG BEI DER HERSTELLUNG PHARMAZEUTISCHER FORMULIERUNGEN ZUR BEHANDLUNG UND PRÄVENTIONRVENSYSTEMS - Google Patents
DARSTELLUNG VON 1-AZA-2-OXADIBENZOÄe,hÜAZULENEN UND DEREN VERWENDUNG BEI DER HERSTELLUNG PHARMAZEUTISCHER FORMULIERUNGEN ZUR BEHANDLUNG UND PRÄVENTIONRVENSYSTEMSInfo
- Publication number
- DE602004018675D1 DE602004018675D1 DE602004018675T DE602004018675T DE602004018675D1 DE 602004018675 D1 DE602004018675 D1 DE 602004018675D1 DE 602004018675 T DE602004018675 T DE 602004018675T DE 602004018675 T DE602004018675 T DE 602004018675T DE 602004018675 D1 DE602004018675 D1 DE 602004018675D1
- Authority
- DE
- Germany
- Prior art keywords
- oxadibenzoes
- haazules
- aza
- prevention
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Vascular Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HR20030953A HRP20030953A2 (en) | 2003-11-21 | 2003-11-21 | PREPARATION OF 1-AZA-2-OXA-DIBENZO[e,h]AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
PCT/HR2004/000050 WO2005049623A1 (en) | 2003-11-21 | 2004-11-19 | PREPARATION OF 1-AZA-2-OXA-DIBENZO[e,h]AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004018675D1 true DE602004018675D1 (de) | 2009-02-05 |
Family
ID=34611157
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004018675T Active DE602004018675D1 (de) | 2003-11-21 | 2004-11-19 | DARSTELLUNG VON 1-AZA-2-OXADIBENZOÄe,hÜAZULENEN UND DEREN VERWENDUNG BEI DER HERSTELLUNG PHARMAZEUTISCHER FORMULIERUNGEN ZUR BEHANDLUNG UND PRÄVENTIONRVENSYSTEMS |
Country Status (11)
Country | Link |
---|---|
US (1) | US20070078124A1 (de) |
EP (1) | EP1687314B1 (de) |
JP (1) | JP2007511595A (de) |
CN (2) | CN101386623A (de) |
AR (1) | AR047130A1 (de) |
AT (1) | ATE418558T1 (de) |
CA (1) | CA2546620A1 (de) |
DE (1) | DE602004018675D1 (de) |
ES (1) | ES2319904T3 (de) |
HR (1) | HRP20030953A2 (de) |
WO (1) | WO2005049623A1 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5528699B2 (ja) | 2006-05-16 | 2014-06-25 | 武田薬品工業株式会社 | 縮合複素環化合物およびその用途 |
EP2789338A3 (de) | 2007-11-15 | 2015-01-14 | Takeda Pharmaceutical Company Limited | Kondensiertes Pyridinderivat und seine Verwendung |
JPWO2019131902A1 (ja) | 2017-12-27 | 2020-12-10 | 武田薬品工業株式会社 | 腹圧性尿失禁および便失禁の治療薬 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3711489A (en) * | 1971-03-31 | 1973-01-16 | Pfizer | Certain 8,9-dihydro(3,4,7,8)cycloocta(1,2-d)imidazoles |
NL7605526A (nl) * | 1976-05-24 | 1977-11-28 | Akzo Nv | Nieuwe tetracyclische derivaten. |
US4198421A (en) * | 1978-11-30 | 1980-04-15 | E. I. Du Pont De Nemours And Company | Antiinflammatory 2-substituted-dibenzo[2,3:6,7]oxepino[4,5-d]imidazoles |
FR2504140A1 (fr) * | 1981-04-16 | 1982-10-22 | Centre Nat Rech Scient | Nouveaux derives tetracycliques de la dibenzazepine, leur procede de preparation et les compositions pharmaceutiques en renfermant |
US5552399A (en) * | 1994-11-02 | 1996-09-03 | Janssen Pharmaceutica N.V. | Substituted tetracyclic azepine derivatives |
ES2196328T3 (es) * | 1996-04-12 | 2003-12-16 | Janssen Pharmaceutica Nv | Derivados de tetrahidrofurano tetraciclicos sustituidos. |
UA52778C2 (uk) * | 1997-10-10 | 2003-01-15 | Янссен Фармацевтика Н.В. | Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі |
-
2003
- 2003-11-21 HR HR20030953A patent/HRP20030953A2/xx not_active Application Discontinuation
-
2004
- 2004-11-19 JP JP2006540627A patent/JP2007511595A/ja active Pending
- 2004-11-19 US US10/595,939 patent/US20070078124A1/en not_active Abandoned
- 2004-11-19 EP EP04798729A patent/EP1687314B1/de active Active
- 2004-11-19 CA CA002546620A patent/CA2546620A1/en not_active Abandoned
- 2004-11-19 ES ES04798729T patent/ES2319904T3/es active Active
- 2004-11-19 WO PCT/HR2004/000050 patent/WO2005049623A1/en active Application Filing
- 2004-11-19 DE DE602004018675T patent/DE602004018675D1/de active Active
- 2004-11-19 AT AT04798729T patent/ATE418558T1/de not_active IP Right Cessation
- 2004-11-19 CN CNA2008102138307A patent/CN101386623A/zh active Pending
- 2004-11-19 CN CNB2004800394559A patent/CN100429214C/zh not_active Expired - Fee Related
- 2004-11-22 AR ARP040104305A patent/AR047130A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AR047130A1 (es) | 2006-01-11 |
CN1902206A (zh) | 2007-01-24 |
EP1687314A1 (de) | 2006-08-09 |
ES2319904T3 (es) | 2009-05-14 |
CA2546620A1 (en) | 2005-06-02 |
CN101386623A (zh) | 2009-03-18 |
CN100429214C (zh) | 2008-10-29 |
HRP20030953A2 (en) | 2005-10-31 |
ATE418558T1 (de) | 2009-01-15 |
WO2005049623A1 (en) | 2005-06-02 |
EP1687314B1 (de) | 2008-12-24 |
US20070078124A1 (en) | 2007-04-05 |
JP2007511595A (ja) | 2007-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE518841T1 (de) | Herstellung und verwendung von arylalkylsäurederivaten zur behandlung von obesitas | |
DE50015883D1 (de) | Flächiges Implantat, Verfahren zu seiner Herstellung und Verwendung in der Chirurgie | |
ATE551100T1 (de) | Pharmazeutische zusammensetzung zur behandlung von kardiovaskulären und cerebrovasakulären erkrankungen | |
DE60317918D1 (de) | Tricyclische verbindungen zur behandlung von entzündlichen- und allergischen erkrankungen: verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
DE60045394D1 (de) | Zusammensetzungen gegen infektionen zur behandlung erkrankten gewebes wie z.b. fieberbläschen | |
ATE512163T1 (de) | Verabreichung von mitteln zur behandlung von entzündungen | |
DE602005027546D1 (de) | Aryl- und heteroarylpiperidincarboxylatderivate, deren herstellung und deren verwendung in form von faah-enzyminhibitoren | |
ATE389649T1 (de) | Substituierte amin-derivate und deren verwendung zur behandlung von angionese-bedingten erkrankungen | |
EP2497478A3 (de) | Oligosaccarid-Zusammensetzungen und ihre Verwendung bei der Behandlung von Infektionen | |
ID26773A (id) | Sulfur tersubstitusi pada asam sulfonilaminokarboksilat n-arilamida, persiapan, penggunaan dan persiapan pembuatan obat yang menyertainya | |
WO2004006858A3 (en) | Compounds, compositions, and methods employing same | |
ATE374204T1 (de) | Thienopyrimidinedione und deren verwendung in der behandlung von autoimmunerkrankungen | |
DE602004022036D1 (de) | Verfahren zur behandlung von atherosklerose, dyslipidämie und verwandten erkrankungen und pharmazeutische zusammensetzungen | |
HK1090936A1 (en) | Amphiphilic block copolymer and polymeric composition comprising the same for drug delivery | |
DE50007778D1 (de) | Reinigungselement, insbesondere zur reinigung von zähnen und verfahren zu seiner herstellung | |
DK1654253T3 (da) | Substituerede 3-pyrrolidinindolderivater | |
DE60307766D1 (de) | Gewürzmittel und Verfahren zu seiner Herstellung | |
DE60120416D1 (de) | Polyaminoestern und deren verwendung zur herstellung von dentalmassen | |
DE60328502D1 (de) | Verfahren zur herstellung von 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazolen aus cyclohexanen und cycylohexanonen als zwischenprodukte | |
DE602004027730D1 (de) | Medizinisches knochenprothesematerial und verfahren zu seiner herstellung | |
ATE522205T1 (de) | Testosteronhaltiges transdermales therapeutisches system und verfahren zu seiner herstellung | |
DE60028757D1 (de) | Polyolefinzusammensetzung, verfahren zur herstellung und die verwendung davon | |
DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten | |
DE69809284D1 (de) | Immunomodulator mit anti-mikrobakteriellen und anti-mykobakteriellen eigenschaften, verfahren zu seiner herstellung und pharmazeutische zusammensetzungen zur behandlung von mykobakteriosen sowie von chronischen und nicht-spezifischen lungenzuständen, sexuell übertragbaren krankheiten und den daraus resultierenden immunschwächen | |
DE602004018675D1 (de) | DARSTELLUNG VON 1-AZA-2-OXADIBENZOÄe,hÜAZULENEN UND DEREN VERWENDUNG BEI DER HERSTELLUNG PHARMAZEUTISCHER FORMULIERUNGEN ZUR BEHANDLUNG UND PRÄVENTIONRVENSYSTEMS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |